BioSpace News Archive

The healthcare data interoperability market is expected to be driven by increasing spending on healthcare across developed as well as developing countries.

Teligent, Inc. (Nasdaq: TLGT), (“Teligent” or the “Company”), a New Jersey -based specialty generic pharmaceutical company, today announced it has appointed Carter Pate to its Board of Directors

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced expanded capabilities that enable clinicians to use its advanced clinical chatbot Gia to guide their patients in an intuitive conversation

Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced that it will report its fourth quarter and year end 2020 financial results after market close on Tuesday, March 2 , 2021.

Encompass Health Corp. (NYSE: EHC) today announced it will participate in the Barclays Global Healthcare Conference, which is being held as a virtual event, on March 9-11, 2021 .

Addition of IDTF operation has CBSC well-positioned to significantly impact the US Remote Patient Monitoring market. ESCONDIDO, CA / ACCESSWIRE / February 23, 2021 / CB Scientific, Inc. (OTC PINK:CBSC) (“CBSC” or the “Company”), in an ongoing effort to expand its outreach in the Ambulatory Remote Cardiac Diagnostic Monitoring Services market in the United States, is pleased to announce a definitive purchase agreement to acquire Cardiolink Corporation, a Medicare-certif

Medcura, Inc., a commercial-stage medical device company, announced that it has been awarded a $2M follow-on grant to expand its implantable products program based, in part, on successful results under a previous grant from the U.S. Military.

Intercept Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, announced the appointment of Dagmar Rosa-Bjorkeson to its Board of Directors as of April 1, 2021.

Jounce Therapeutics, Inc., a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, announced that Jounce management will present at several upcoming investor conferences

Krystal Biotech Inc. , (“Krystal”) (NASDAQ: KRYS), the leader in redosable gene therapies for rare diseases, today announced that Krish S. Krishnan, Chairman and Chief Executive Officer will be participating in a fireside chat at the 41 st Annual Cowen Health Care Conference taking place March 1-4, 2021.